Investor Archive - Page 161 of 170 - Wockhardt

WOCKHARDT RECEIVES US FDA APPROVAL FOR GENERIC VERSION OF EFFEXOR XR® CAPSULES

For Quarter-ended Mar 31, 2011

WOCKHARDT AND SHEFFIELD BIO-SCIENCE, USA ANNOUNCE A STRATEGIC ALLIANCE TO DISTRIBUTE RECOMBINANT INSULIN IN CELL CULTURE MARKETS GLOBALLY

FINANCIAL RESULTS FY11 Q3

Wockhardt launches generic version of Protonix tablets in the US

For the Quarter Ended 31st December, 2010

QUARTERLY Reports (Q2)

FINANCIAL RESULTS FY11 Q2

Wockhardt receives US FDA approval for the generic version of Allegra-D® 12 Hour

CHAIRMAN’S AGM Speech 2010